Business Wire

Brenus Pharma unveils promising pre-clinical results extrapolating human conditions in major international congresses.

Share

Brenus Pharma announces that pre-clinical advancements of its inaugural research program were presented at the 7th CICON (International Cancer Immunotherapy) Conference in Milan, Italy (September 20-23) and will be showcased at the 38th Annual SITC (Society for Immunotherapy of Cancer) Congress in San Diego, CA, USA (November 1-5)

These communications focus on pre-clinical validation of new developments of the first product generated by the STC Platform, STC-1010, which targets colorectal cancer in a first line of treatment.

CONFERENCE

TITLE

AUTHORS

RESULTS

CICON23

P119: Allogenic Tumor Cell-Based Vaccine to Treat Colorectal Cancer: Development and Preclinical Validation

SEE POSTER

SITC23

Stimulated Tumor Cells (STC) Vaccine Induce Response in Colorectal Cancer

TO COME

Benoit PINTEUR, (Pharm.D), Co-Founder and Chief Scientific Officer at Brenus Pharma explains: "After testing the STC product on colorectal cancer models in syngeneic immunocompetent mice (in vivo), where results have shown improved overall survival and enhanced immune response with STC-1010, we tested new models (ex vivo, in ovo) to enhance human extrapolation to validate the STC-1010 biological mechanism of action and replicate excellent results on human colorectal cancer models. All our efforts are now focused on regulatory approvals and batch production for the clinical trial in 2024."

About STC Platform: "Stimulated-Tumor-Cells" is the first technology platform that generates cancer vaccines, based on cells that are stimulated to reproduce antigenic relapsing-tumor signatures; and haptenized to educate the immune system against resistant tumors. It breaks through current limitations by efficiently treating solid tumors, ensuring cost and supply control.

For further information: www.brenus-pharma.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

CONTACT BRENUS
Marion Brun
Communication Manager
contact@brenus-pharma.com
+ 33 (0)7 87 76 87 72

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ansys and IonQ Are Bringing the Power of Quantum to the $10 Billion Dollar Computer-Aided Engineering Industry6.11.2024 22:10:00 CET | Press Release

IonQ (NYSE: IONQ), a leader in the quantum computing industry, and Ansys (Nasdaq: ANSS), have joined forces to integrate quantum computing into the $10B computer-aided engineering (CAE) industry.* Together, IonQ and Ansys aim to accelerate simulation, expand high-fidelity design exploration, and reduce product development timelines, enabling faster market entry for innovative products. This partnership aims to make simulation accessible to both quantum experts and non-experts, with the goal of enhancing enterprise value and streamlining product development processes. Ansys solutions are used in product development across industries and account for a significant portion of all modeling and simulation in the CAE market. As IonQ’s quantum computers advance and outpace classical systems on specific tasks, integrating them with Ansys’ technology for complex simulations will open the door to new discoveries and innovations. With these advancements, Ansys will gain access to critical infrastr

Pure Lithium Announces New York Series B Roadshow6.11.2024 21:10:00 CET | Press Release

Pure Lithium Corporation, a disruptive Boston-based vertically-integrated lithium metal battery technology company, is pleased to announce that it will conduct a roadshow in New York the week of November 18, 2024 to promote its $75M to $100M Q1 2025 Series B fundraise. The funds will support the scale-up of the Company’s technology towards commercial lithium metal battery production and a potential Initial Public Offering of the company. Lithium metal is the "holy grail" of energy storage, a step change beyond today's lithium-ion battery. It does not require graphite, nickel, cobalt and manganese, eliminating dependence on China and enabling local battery hubs in favorable jurisdictions for the first time ever. Since opening its Boston lab in January of 2021, Pure Lithium has made impressive strides towards commercializing the lithium metal battery. This year, the Company raised $20M in its Series A.5 with Oxy Low Carbon Ventures as the lead investor. Major progress has been made on a

Perma-Pipe International Holdings, Inc. Announces $15 Million in Contract Awards in the Americas and Middle East Regions6.11.2024 20:01:00 CET | Press Release

Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) today announced $6 million in new project awards in the MENA region. Additionally, the company announced $9 million in new project awards in the Americas, demonstrating continual improvement in the region. These new project awards will utilize Perma-Pipe’s anti-corrosion coatings capabilities and the XTRU-THERM® insulation system, a spray-applied polyurethane foam jacketed with a high-density polyethylene casing. These new project awards further complement our backlog, which has experienced considerable growth. Backlog was $75.0 million at July 31, 2024 and is now in excess of $100.0 million. Marc Huber, Sr. Vice President for Perma-Pipe’s Americas region, commented, “We are delighted with these awards which demonstrate the buoyancy in the Americas market and the continual strengthening of our position in the USA and Canada.” Saleh Sagr, Sr. Vice President for Perma-Pipe’s MENA region, commented, “The latest awards in MENA largely

Mouser Electronics Examines the Human-Centric Revolution of Industry 5.06.11.2024 18:11:00 CET | Press Release

Mouser Electronics, Inc., the global authorized distributor renowned for providing the latest in electronic components and industrial automation solutions, today unveiled the newest chapter in its Empowering Innovation Together (EIT) technology series, which focuses on the emerging landscape of Industry 5.0. In this next phase of industrialization, human, environmental, and social considerations will factor into the advanced technology, robotics, and smart machines on the factory floor of the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241106421709/en/ For the last several decades, the manufacturing world has been integrating robots into factory control systems—a move compared to a fourth industrial revolution and named Industry 4.0. Now, Industry 5.0 puts people at the heart of manufacturing bringing technology and humanity closer together. (Graphic: Business Wire) Building on the technological advancements of In

Building a World-Class Synthetic Biology Lab: Asymchem’s Self-Developed STAR System Empowers Protein Design6.11.2024 17:00:00 CET | Press Release

Asymchem (stock code: 002821.SZ/6821.HK), a leading global contract development and manufacturing organization (CDMO), has created an artificial intelligence (AI) platform to address key challenges in protein design. This platform, known as STAR (Sequence Recommendation via Artificial Intelligence), was successfully developed by Asymchem’s Center of Synthetic Biology Technology (CSBT) and AI team. The team published a paper titled “STAR: A Web Server for Assisting Directed Protein Evolution with Machine Learning” in ACS Omega, detailing the system’s ability to integrate multiple machine learning models and sequence encoding methods. One major challenge in protein engineering is the number of mutations that need to be generated and screened. This can take anywhere from 3 to 6 months. STAR dramatically accelerates this process. By leveraging machine learning, the platform quickly identifies critical regions for mutation. This reduces the number of experimental samples to just a few hundr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye